These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1396837)

  • 21. An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.
    Brignole M; Menozzi C; Gasparini M; Bongiorni MG; Botto GL; Ometto R; Alboni P; Bruna C; Vincenti A; Verlato R;
    Eur Heart J; 2002 Jun; 23(11):892-900. PubMed ID: 12042011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective long-term ECG study of 100 patients surviving sudden cardiac death].
    Herms J; Siebels J; Schneider M; Kuck KH
    Z Kardiol; 1992 Dec; 81(12):673-80. PubMed ID: 1492436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incessant idiopathic ventricular tachycardia in infants].
    Villain E; Bonnet D; Kachaner J; Le Bidois J; Cohen L; Piéchaud JF; Sidi D
    Arch Mal Coeur Vaiss; 1990 May; 83(5):665-71. PubMed ID: 2114081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of the efficacy/tolerability ratio of cibenzoline and propafenone in the treatment of ventricular arrhythmia].
    Babuty D; Cosnay P; Rouesnel P; Bine-Scheck F; Arnaud R; Fauchier JP
    Ann Cardiol Angeiol (Paris); 1992 Apr; 41(4):225-34. PubMed ID: 1642441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proarrhythmic effects of class Ic drugs.
    Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K
    Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
    Chimienti M; Cullen MT; Casadei G
    Am J Cardiol; 1996 Jan; 77(3):60A-75A. PubMed ID: 8607393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
    Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G
    G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chaotic atrial rhythm in children.
    Dodo H; Gow RM; Hamilton RM; Freedom RM
    Am Heart J; 1995 May; 129(5):990-5. PubMed ID: 7732989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of associated propafenone in patients with amiodarone-resistant ventricular tachycardia.
    Morgera T; Dreas L; Humar F; Maras P; Chersevani D; Camerini F
    Int J Cardiol; 1991 May; 31(2):187-97. PubMed ID: 1869328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
    Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
    Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the Risk for Peripheral Neuropathy in Patients Treated With Dronedarone Compared With That in Other Antiarrhythmics.
    Wu C; Tcherny-Lessenot S; Dai W; Wang Y; Kechemir H; Gandhi S; Lin S; Juhaeri J
    Clin Ther; 2018 Mar; 40(3):450-455.e1. PubMed ID: 29500139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Class IC drugs: propafenone and flecainide.
    Puech P; Gagnol JP
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():549-53. PubMed ID: 2125832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuation of antiarrhythmic drugs, or arrhythmia surgery after multiple drug failures. A randomized trial in the treatment of postinfarction ventricular tachycardia.
    van Hemel NM; Kingma JH; Defauw JJ; Hoogteijling-van Dusseldorp E; Kelder JC; Beukema WP; Vermeulen FE
    Eur Heart J; 1996 Apr; 17(4):564-73. PubMed ID: 8733090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti-arrhythmia agents in heart failure].
    Brakhmann I; Shmitt K; Baĭer T; Valdeker B; Khilbel T; ShvaĭtserM ; Kiubler V
    Kardiologiia; 1992 Apr; 32(4):38-40. PubMed ID: 1405232
    [No Abstract]   [Full Text] [Related]  

  • 38. Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.
    Bryson HM; Palmer KJ; Langtry HD; Fitton A
    Drugs; 1993 Jan; 45(1):85-130. PubMed ID: 7680987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid suppression of flecainide-induced incessant ventricular tachycardia with high-dose intravenous amiodarone.
    Sagie A; Strasberg B; Kusniec J; Sclarovsky S; Rechavia E; Agmon J
    Chest; 1988 Apr; 93(4):879-80. PubMed ID: 3127126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic therapy in patients with congestive heart failure.
    Conti JB; Curtis AB
    Postgrad Med; 1993 Oct; 94(5):121-4, 133-7. PubMed ID: 8415326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.